This is a Shannon Award providing partial support for research projects that fall short of the assigned institute's funding range but are in the margin of excellence. The Shannon award is intended to provide support to test the feasibility of the approach; develop further tests and refine research techniques; perform secondary analysis of available data sets; or conduct discrete projects that can demonstrate the PI's research capabilities or lend additional weight to an already meritorious application. Further scientific data for the CRISP System are unavailable at this time.

Agency
National Institute of Health (NIH)
Institute
National Institute on Deafness and Other Communication Disorders (NIDCD)
Type
Research Project (R01)
Project #
5R01DC002285-02
Application #
2683921
Study Section
Special Emphasis Panel (ZRG1-SEN (01))
Project Start
1997-04-01
Project End
2000-03-31
Budget Start
1998-04-01
Budget End
1999-03-31
Support Year
2
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of Iowa
Department
Public Health & Prev Medicine
Type
Schools of Medicine
DUNS #
041294109
City
Iowa City
State
IA
Country
United States
Zip Code
52242
Roy, Nelson; Merrill, Ray M; Thibeault, Susan et al. (2004) Voice disorders in teachers and the general population: effects on work performance, attendance, and future career choices. J Speech Lang Hear Res 47:542-51
Thibeault, Susan L; Merrill, Ray M; Roy, Nelson et al. (2004) Occupational risk factors associated with voice disorders among teachers. Ann Epidemiol 14:786-92
Roy, Nelson; Merrill, Ray M; Thibeault, Susan et al. (2004) Prevalence of voice disorders in teachers and the general population. J Speech Lang Hear Res 47:281-93
Roy, Nelson; Weinrich, Barbara; Gray, Steven D et al. (2002) Voice amplification versus vocal hygiene instruction for teachers with voice disorders: a treatment outcomes study. J Speech Lang Hear Res 45:625-38
Roy, N; Gray, S D; Simon, M et al. (2001) An evaluation of the effects of two treatment approaches for teachers with voice disorders: a prospective randomized clinical trial. J Speech Lang Hear Res 44:286-96